Screening of patients taking vigabatrin.
Rebolleda
G
G
Muñoz-Negrete
F J
FJ
Gutierrez
C
C
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D002648:Child; D004585:Electrooculography / Q000187:drug effects; D004596:Electroretinography / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D020888:Vigabatrin / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced* / Q000175:diagnosis; D014792:Visual Acuity / Q000187:drug effects*; D014794:Visual Fields / Q000187:drug effects*
D000927:Anticonvulsants; D004791:Enzyme Inhibitors; D020888:Vigabatrin